-
1
-
-
0028271564
-
A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic
-
Beer B, Ieni J, Wu W-H, et al. A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic. J Clin Pharmacol 1994;34:335-44.
-
(1994)
J Clin Pharmacol
, vol.34
, pp. 335-344
-
-
Beer, B.1
Ieni, J.2
Wu, W.-H.3
-
2
-
-
0033832307
-
Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia
-
Hedner J, Yaeche R, Emilien G, Farr I, Saunas E. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. Int J Geriatr Psychiatry 2000;15:704-12.
-
(2000)
Int J Geriatr Psychiatry
, vol.15
, pp. 704-712
-
-
Hedner, J.1
Yaeche, R.2
Emilien, G.3
Farr, I.4
Saunas, E.5
-
3
-
-
0344631569
-
Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic
-
Elie R, Rüther E, Farr I, Emilien G, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry 1999;60:536-44.
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 536-544
-
-
Elie, R.1
Rüther, E.2
Farr, I.3
Emilien, G.4
Salinas, E.5
-
4
-
-
0002166750
-
A five-week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia
-
Walsh J, Vogel G, Scharf M, et al. A five-week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Med 2000;1:41-9.
-
(2000)
Sleep Med
, vol.1
, pp. 41-49
-
-
Walsh, J.1
Vogel, G.2
Scharf, M.3
-
5
-
-
0031787070
-
Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance
-
Vermeeren A, Danjou P, O'Hanlon J. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol Clin Exp 1998;13:S98-107.
-
(1998)
Hum Psychopharmacol Clin Exp
, vol.13
-
-
Vermeeren, A.1
Danjou, P.2
O'Hanlon, J.3
-
6
-
-
0346156005
-
A laboratory evaluation of performance following a daytime nap under zaleplon and placebo conditions
-
Whitmore J, Fischer Jr J, Barton E, Storm W. A laboratory evaluation of performance following a daytime nap under zaleplon and placebo conditions. Aviat Space Environ Med 2004;75:29-36.
-
(2004)
Aviat Space Environ Med
, vol.75
, pp. 29-36
-
-
Whitmore, J.1
Fischer Jr., J.2
Barton, E.3
Storm, W.4
-
7
-
-
42049091561
-
Report of the committee on methods of clinical examination in electroencephalography
-
Jasper H. Report of the committee on methods of clinical examination in electroencephalography. Electroencephalogr Clin Neurophysiol 1958;10:370-5.
-
(1958)
Electroencephalogr Clin Neurophysiol
, vol.10
, pp. 370-375
-
-
Jasper, H.1
-
8
-
-
0019480282
-
The circadian variation of experimentally displace sleep
-
Akerstedt T, Gillberg M. The circadian variation of experimentally displace sleep. Sleep 1981;4:159-69.
-
(1981)
Sleep
, vol.4
, pp. 159-169
-
-
Akerstedt, T.1
Gillberg, M.2
-
9
-
-
0020464428
-
Circadian variation of sleep tendency in elderly and young adult subjects
-
Richardson G, Carskadon M, Orav E, Dement W. Circadian variation of sleep tendency in elderly and young adult subjects. Sleep 1982;5:S82-94.
-
(1982)
Sleep
, vol.5
-
-
Richardson, G.1
Carskadon, M.2
Orav, E.3
Dement, W.4
-
10
-
-
0346598443
-
-
Neuilly-Sur-Seine, France: NATO; Report # RTO-EN-016;9.1-9.20
-
Stone B. Sleep promoting substances. Neuilly-Sur-Seine, France: NATO; 2001 Report # RTO-EN-016;9.1-9.20.
-
(2001)
Sleep Promoting Substances
-
-
Stone, B.1
|